Background Tracking of aid resources to reproductive, maternal, newborn, and child health (RMNCH) provides timely and crucial information to hold donors accountable. For the fi rst time, we examine fl ows in offi cial development assistance (ODA) and grants from the Bill & Melinda Gates Foundation (collectively termed ODA+) in relation to the continuum of care for RMNCH and assess progress since 2003.
Introduction
With only 6 months remaining to reach the 2015 deadline of the Millennium Development Goals (MDGs), progress on the targets for child survival (MDG 4) and maternal and reproductive health (MDG 5) has been uneven. Achievements include almost halving child and maternal mortality since 2000, but further eff orts are required to drive down mortality and increase access to reproductive health services. 1, 2 Offi cial development assistance (ODA), as well as private foundation grant making for global health, surged after the MDG summit in 2000, but the extended period of economic austerity since 2007-08 has slowed the growth of this aid. 3 However, high level commitments have been made since 2010 to accelerate progress on MDGs 4 and 5. These include pledges of US$40 billion from 2010-15 towards the Global Strategy for Women's and Children's Health, incorporating $5 billion promised by the G8 and other donors, including the Bill & Melinda Gates Foundation under the Muskoka Initiative. 4 Although welcomed, these pledges might fall short of the estimated annual requirements to meet the health-related MDGs of between $10 billion and $33·9 billion. [5] [6] [7] [8] There has been growing attention to resource tracking and assessment of whether commitments are honoured, with initiatives undertaken by the Institute for Health Metrics and Evaluation (IHME), 9 the Partnership for Maternal, Newborn and Child Health (PMNCH), 6 and the Resource Flows project of the United Nations Population Fund (UNFPA) and the Netherlands Interdisciplinary Demographic Institute (NIDI). This paper contributes to these accountability eff orts and seeks to understand whether donor resources are better targeted to countries with the highest need as we approach 2015. We build on past analyses undertaken for the Countdown to 2015 initiative to track donor funding to reproductive, maternal, newborn, and child health (RMNCH) con sidering the full continuum of care, with a particular focus on the 75 Countdown countries where more than 95% of all maternal and child deaths occur. 10, 11 We analyse trends in donor funding to MNCH for the period 2003-12 and to reproductive health for the period 2009-12.
Methods

Data sources
ODA disbursement data for 2011 and 2012 were downloaded from the creditor reporting system of the Organisation for Economic Co-operation and Development (OECD) on March 12, 2014 . Disbursement data from the Bill & Melinda Gates Foundation were downloaded from the same source on June 24, 2014. We tracked disbursements to all recipient countries worldwide (147 countries in 2011 and 148 in 2012), from all donors reporting to the creditor reporting system (47 donors in 2011 and 49 in 2012). We also reviewed private grants from the Bill & Melinda Gates Foundation, which began reporting to the creditor reporting system in 2009. Although grants from the Bill & Melinda Gates Foundation are not regarded as ODA, these projects are included in our analyses and estimates from previous years updated accordingly. We refer to ODA+ when reporting aggregated results that include these grants. We also analysed data for disbursements from the 31 donors (23 bilateral, six multilaterals, and two global health initiatives) that have reported to the creditor reporting system consistently since we began this resource-tracking exercise, to the Countdown priority countries, of which there are now 75, including South Sudan in 2011, which had previously been included within data reported for Sudan. To avoid double counting, the OECD defi nitions were used to classify aid as bilateral, where the recipient country or purpose of aid is specifi ed by the donor government, and as multilateral for disbursements from multilateral institutions with governmental membership where the recipient country or purpose of aid is specifi ed by the multilateral institution. The allocation of unspecifi ed regional disbursements to individual recipient countries was based on their year-specifi c share of direct regional disbursements. 12 
Data coding
We scanned and coded 507 954 disbursement records for the period 2011 and 2012 across all sectors, including 5858 records from the Bill & Melinda Gates Foundation, according to a previously developed framework. [12] [13] [14] [15] The 2003-10 datasets were not updated, thus any changes to the datasets by the OECD since the initial download were not analysed. Reproductive health expenditures (termed R*) included expenditures on family planning, sexual health, and sexually transmitted infections, including HIV. 16 Maternal and newborn health expenditures included activities to restore, improve, and maintain the health of women and their newborns during pregnancy, childbirth, and the fi rst month of life. 15 Expenditures for child health included activities to restore, improve, and maintain the health of children up to 5 years of age. 15 Where age was unclear, we assumed the term child referred to children younger than 5 years. To identify expenditures that mentioned or exclusively benefi ted newborns, an automated key term search was applied to the full creditor reporting system dataset. 17 Such expenditures were classifi ed as exclusively benefi ting newborns, or as inclusive if they also aimed to improve the health of other population groups. Funding for research activities was excluded.
To maximise coding consistency across years, we compared records from 2011 and 2010, and 2012 and 2011 with an exact string non-case-sensitive matching system. Where records shared the same donor and recipient country name, project title, and short description, the 2010 (2011) code was assigned to the 2011 (2012) record. Slightly more than 35% of each year's records were coded in this way. Remaining records were manually coded by four coders by reading the project title, and short and long descriptions prior to assigning a code. Intercoder consistency was evaluated with Krippendorff 's α on a sample of 1270 records. A value of more than 0·9 was noted among three of the coders, with the remaining coder scoring 0·7. All records coded by this coder were recoded by a second coder, and diff erences solved by discussion.
As in previous years, we included funding exclusively earmarked for RMNCH and allocated a share of other activities thought to benefi t RMNCH, including funds for general health systems or health care, general budget support, basket or health sector funding (eg, (such as the sector wide approach [SWAp]), and some condition-specifi c funding (for example, malaria and HIV). Country-specifi c allocation factors were used for condition-specifi c funding based on the latest estimates of the crude birth rate; the total under-5 population; 18 the number of children and people of reproductive age living with HIV; and the prevalence of people living with any of four sexually transmitted diseases (Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, and Trichomonas vaginalis). 19, 20 For general budget support, allocation factors were obtained from the National Health Accounts database. The allocation of health systems funds and basket or sector funding was fi xed across countries and based on the literature.
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Statistical analysis
We analysed trends in donor funding to MNCH for the period 2003-12 and to R* for the period 2009-12. We examined variation in funding levels with time for every donor and by donor type (bilateral, multilateral, global health initiative, and private foundation). We also analysed trends in funding by modality (pooled funding vs project funding), and by project type. Finally, we considered variation in funding levels to recipient countries and regions over time. All data from the period 2003-12 were converted to constant 2012 US$ with the donor-specifi c development assistance committee defl ators. 21 We assessed the extent to which donors targeted their development assistance based on country need and whether targeting improved with time. A series of univariate ordinary least squares regressions were estimated to evaluate whether ODA+ was targeted to countries with higher under-5 mortality rates, 22 higher maternal mortality, 23 higher HIV prevalence, 19 and lower female life expectancy at birth 24 for 3 years, 2005, 2010, and 2012. Disbursements from all donors to all countries receiving ODA+ were included. The fi rst model used the natural logarithm of ODA+ to child health per child as the dependant variable and the under-5 mortality rate (deaths per 1000 children younger than 5 years) as the independent variable; the second model used the natural logarithm of ODA+ to maternal and newborn health per livebirth as the dependant variable and the maternal mortality ratio (maternal deaths per 100 000 livebirths) as the independent variable; and the third and fourth models used the natural logarithm of ODA+ to reproductive health per woman of reproductive age as the dependant variable and HIV prevalence (model 3) and female life expectancy at birth (model 4) as the independent variables. The Huber-White sandwich estimator was used to deal with heteroskedasticity after transforming the dependant variable. Targeting according to need was assessed in relation to the sign and signifi cance (p<0·05) of the coeffi cient on the independent variable, a positive sign on the coeffi cient of the fi rst three models and a negative sign in the fourth model. Targeting was considered to have improved with time if there was an increase in the R² value between years, indicating a better fi t of the data. We tested the signifi cance of the diff erence in the R² value between years using Fischer's Z transformation of correlation coeffi cients followed by a t test for the null hypothesis that the diff erence is equal to zero. We also examined whether targeting diff ered across types of donor (multilateral, bilateral, global health initiatives, and 
Norway *  57·8  49·4  53·0  69·1  88·7  105·2  174·0  31·3  115·4  24·0  110·6  31·4  105·7  22·3   Portugal*  2·4  2·8  4·0  2·8  1·0  1·6  2·4  0·0  5·0  0·4  7·0  0·2  7·2  0·0   Spain*  45·2  43·3  57·0  64·9  163·5  171·0  159·6  17·3  139·4  14·3  54·0  12·0  33·1  3·4   Sweden*  43·7  53·8  80·3  85·7  105·5  92·8  108·1  44·2  87·5  35·8  61·6  48·9  171·5  42·8   Switzerland*  23·6  26·1  17·1  33·3  26·2  31·5  36·4  2·5  35·9  2·1  40·6  5·4  44·1  5·1   United Arab  Emirates   30·5  0·1  19·4  0·3  12·0  0·0  51·5  0·0   UK*  240·1  184·3  332·1  312·7  331·1  425·4  585·5  135·3  500·5  140·7  601·6  259·8  762·2  223·2   USA*  560·3  517·8  922·3  676·0  1038·8  1431·1  1419·7  2278·4  1452·3  2284·9  1471·6  2924·2  1353·1  2780·5 Multilateral aid agencies
EU institutions *  67·6  74·5  172·8  335·9  257·7  351·6  399·4  25·0  393·8  21·7  550·1  14·5  748·2  31·8   GEF  ··  ··  ··  ··  ··  0·3  ··  ··  ··  ··  ··  ··  0·1  0·0   IDA*  460·8  631·8  543·7  1171·6  411·5  334·0  550·1  103·9  350·3  76·7  375·5  85·7  359·9  60·4   IDB Sp Fund  ··  ··  ··  ··  ··  ··  11·2  0·0  10·6  0·0  29·7  0·0  19·2  0·0   IMF  (concessional  trust funds)   ··  ··  ··  ··  ··  ··  ··  ··  43·7  0·0  42·9  0·0  39·1  0·0   IMF (SAF/ESAF/  PRGF)   ··  ··  ··  ··  ··  ··  89·2  0·0  ··  ··  ··  ··  ··  ··   OFID  ··  ··  ··  ··  ··  ··  11·2  0·0  8·9  1·0  4·5  4·4  9·8  2·4   UNAIDS*  4·2  4·0  3·4  3·1  3·9  3·9  2·0  99·6  4·3  72·0  10·7  106·2  8·1  55·0   UNDP*  ··  0·5  0·3  0·4  0·8  1·2  1·2  8·0  0·6  4·9  1·4  6·1  1·5  4·6   UNECE  ··  ··  ··  ··  ··  0·1  ··  ··  0·2  0·0  0·0  0·0  0·2  0·0 ( private donor) by running the same set of regressions for each type of donor. All models were run in Stata version 13.
Role of the funding source
The funder had no role in the study design, data extraction, data analysis, data interpretation, or writing of the report. All authors reviewed drafts of the manuscript, and the corresponding author had fi nal responsibility to submit for publication. All authors had full access to the dataset.
Results
Reported ODA+ from all donors to all sectors and recipients reduced slightly in 2011 relative to 2010 for the fi rst time since 2007, and increased only marginally (0·9%) in 2012 ( (table 1) . Between 2010 and 2011, ODA to child health to the 75 priority countries increased by 4·9%, and ODA to maternal and newborn health reduced by 7·4%, resulting in an overall increase in ODA to MNCH of 1·2% (appendix p 2). However, we noted a sharp increase in ODA to child health and to maternal and newborn health in 2012 (an increase by 14·5% and 22·6%, respectively, relative to 2011 levels; appendix p 2). ODA to R* in the priority countries increased steadily up to $3·0 billion in 2011 (6·8% increase relative to 2010), and to $3·1 billion in 2012 (3·2 % increase relative to 235·4  73·2  193·0  180·3  146·2  136·9  148·3  41·4  143·1  36·6  130·5  49·4  114·6  63·1   UNICEF*  98·2  91·4  114·3  97·9  302·0  200·6  182·4  7·3  186·8  9·9  147·1  11·4  121·5 48·1  48·0  83·9  86·7  121·6  195·7  263·3  27·8  224·2 20·2  283·1  35·1  262·0  34·8   Angola  21·1  15·3  61·1  25·4  52·4  67·2  49·1  9·8  46·5 13·2  33·1  14·9  56·2  14·2   Azerbaijan  1·6  2·1  4·1  3·2  3·7  5·6  6·5  2·3  7·8 4·8  9·0  2·0  6·2 Chad  11·7  19·5  20·3  11·9  20·8  26·1  28·1  4·4  54·7 7·5  33·9  10·4  34·0  4·4   China  66·4  65·2  56·9  69·0  90·0  61·8  63·5  52·4  63·1 41·9  26·0  40·6  40·4  42·7   Comoros  3·5  2·7  2·1  1·4  1·5  1·2  2·1  0·1  5·7 0·1  3·2  0·5  4·3  0·4   DR Congo  37·1  59·7  68·2  88·6  115·6  202·3  227·9  37·0  249·5 68·2  302·4  55·7  310·9  68·2 Congo (Brazzaville)  4·6  5·1  4·4  3·0  7·0  9·2  5·0  3·4  20·8 6·3  13·4  5·7  9·5  2·4   Côte d'Ivoire  12·8  17·8  11·5  10·5  25·3  38·0  38·5  37·0  65·5 45·7  52·5  39·6  51·5  43·3   Djibouti  1·4  4·4  5·9  6·0  14·2  6·5  8·4  1·6  5·2 1·7  6·4  1·3  12·3  0·6   Egypt  11·0  15·1  35·8  50·3  30·7  31·5  26·6  9·3  31·2 5·6  23·7  5·2  23·6  1·4   Equatorial Guinea  1·1  1·4  2·8  5·8  4·2  8·0  6·4  0·7  6·5 1·0  2·4  0·3  1·1  0·1   Eritrea  21·7  18·1  18·4  13·4  16·9  12·7  13·0  9·4  28·8 11·9  12·7  3·9  11·7  9·2   Ethiopia  109·1  75·0  99·9  245·4  238·0  202·3  321·6  122·1  225·1 218·5  349·9  230·7  381·4  166·0   Gabon  0·9  3·6  5·3  4·5  4·3  2·3  3·9  2·7  1·5 1·5  1·7  1·8  1·3  1·3   Gambia  5·6  6·7  9·8  4·3  8·3  6·9  8·3  3·7  12·0 3·6  9·0  3·6  8·6  3·0   Ghana  59·8  79·0  93·3  102·2  81·5  83·2  122·1  38·7  120·6 22·9  109·4  40·7  172·8  25·0   Guatemala  18·2  11·3  17·9  21·4  27·0  35·4  25·6  10·6  17·7 7·7  22·7  13·7  21·5  10·6   Guinea  9·2  8·7  17·5  12·7  12·9  14·1  19·0  8·1  30·6 6·8  15·0  12·3  45·2  7·1   Guinea-Bissau  3·4  3·0  4·9  3·5  6·2  7·0  6·5  3·6  12·4 4·0  6·7  2·6  3·8  0·9   Haiti  5·3  13·9  11·1  22·4  37·7  43·5  41·4  92·2  108·3 89·4  153·7  86·5  81·9  87·4   India  271·7  363·7  432·6  230·4  350·1  374·1  365·1  102·7  373·1 70·0  253·5  137·0  321·8  73·4   Indonesia  75·6  68·3  58·5  120·6  87·0  94·9  98·6  19·4  98·4 14·8  64·1  22·5  93·0  25·4   Iraq  54·3  24·3  113·8  95·5  104·8  25·6  44·7  0·9  42·3 0·6  35·2  0·1  21·0  1·8   Kenya  64·8  64·2  90·1  115·0  92·0  139·0  167·2  207·6  209·8 224·7  194·6  280·9  224·9  351·7   North Korea  4·9  3·7  5·5  4·5  10·3  7·2  9·8  0·0  11·6 0·0  7·9  0·0  12·3  0·6   Kyrgyzstan  20·1  9·1  11·8  12·3  14·1  14·6  14·6  1·9  15·8 2·4  15·0  3·1  13·4  2·5   Laos  11·9  8·1  14·8  11·9  17·3  17·8  17·8  3·0  22·1 2·8  21·7  4·8  23·2  2·4   Lesotho  3·2  3·8  1·6  2·1  4·4  7·0  5·3  16·4  12·8 26·6  16·9  35·6  15·6  41·3   Liberia  9·8  12·8  8·2  17·3  25·1  38·9  54·7  6·0  53·6 11·4  81·1  15·8  57·5  11·5   Madagascar  34·6  38·1  42·7  120·4  55·8  63·7  50·5  6·7  96·5 10·5  61·6  10·4  57·9  15·1   Malawi  51·7  42·7  42·3  87·8  98·3  103·5  155·6  31·9  91·0 62·6  124·5  67·9  154·7  99·0   Mali  20·4  27·7  38·3  70·5  52·4  56·7  67·9  17·5  89·3 14·8  119·5  17·0  134·2  20·1   Mauritania  7·8  8·2  4·5  17·8  10·0  9·1  11·7  0·3  12·7 0·0  11·2  1·2  27·7  1·4   Mexico  6·4  4·7  5·9  4·7  5·0  2·6  2·1  1·1  2·7 1·2  2·1  3·0  3·3  3·9   Morocco  17·2  7·5  11·6  21·0  23·3  14·0  29·0  1·3  26·5 1·9  17·4  4·5  10·3  3·2   Mozambique  67·8  79·5  66·3  113·5  113·3  139·7  121·8  128·9  152·8 141·4  168·6  125·9  176·3  130·0   Myanmar  13·9  12·0  21·7  20·8  17·5  38·6  34·2  2·9  45·9 10·3  35·8  8·5  97·1  9·6   Nepal  22·6  13·6  25·0  30·9  38·8  55·7  52·8  9·7  79·6 11·2  54·3  16·3  50·1  13·8 ( Funding from global health initiatives (Global Fund and GAVI) fell in 2011 to 17% of ODA+ to MNCH, from 21% in 2010, and increased again in 2012 to 21% (table 2; appendix p 4). MNCH funding from GAVI increased by 2·1% in 2011 relative to 2010 (from $697 million to $712 million), while funding from the Global Fund decreased by 34% in the same period (from $809 million to $537 million), due to reductions in funding for malaria (table 2) .
More than 70% of ODA+ to R* comes from bilateral donors, with less than 20% coming from global health initiatives and less than 7% from multilaterals (table 2; appendix p 5). US contributions to R* exceeded $2·7 billion in 2011 and 2012, more than 3·5 times more than the next largest donor, and more than 1·9 times more than US contributions to MNCH.
The share of project-based funding to MNCH was at the highest level in 2012 (96·7%) since resource-tracking commenced (tables 3 and 4). The value of projects to strengthen health systems assumed to benefi t RMNCH continued to increase in 2011 and 2012. Funding for immunisation and nutrition reached the highest levels since 2003, although ODA to immunisation represents a constant share of total MNCH funding since 2010. Two-thirds of nutrition funding was provided by Canada, the European Union, and Australia. Within ODA to R*, ODA to sexual health and sexually transmitted diseases has reduced, whereas ODA to HIV projects has continued to increase, accounting for more than 80% of all ODA to R* in 2011 and 2012. 14·7  17·2  25·1  63·8  47·0  67·4  63·2  10·9  87·8 3·8  69·2  11·4  98·5  6·8   Nigeria  68·7  94·0  111·4  157·2  193·7  268·9  462·0  220·0  225·6 222·3  296·8  207·3  396·6 239·5
Sierra Leone  8·9  9·6  13·2  19·6  35·3  27·4  42·7  8·9  44·3 12·9  46·0  10·0  30·5  19·4   Solomon Islands  7·0  8·5  2·0  7·1  6·7  10·8  13·1  0·9  16·7 0·5  15·9  0·5  8·3  0·1   Somalia  8·1  11·0  10·2  17·0  29·0  35·5  57·2  1·8  47·3 6·6  28·1  5·6  99·0  1·8   South Africa  16·2  13·5  28·1  26·6  24·7  74·1  30·9  367·6  16·0 361·2  46·7  347·9  47·7  352·7   South Sudan  0·0  0·0  0·0  0·0  0·0  0·0  0·0  0·0  0·0 0·0  51·7  16·1  144·6  17·8   Sudan  14·7  42·0  82·0  65·8  101·2  128·9  140·8  9·1  178·9 26·7  128·0  9·9  175·1  4·9   Swaziland  1·1  0·3  1·4  1·2  2·8  3·2  4·5  16·3  3·7 34·5  8·3  32·2  4·0  26·9   Tajikistan  8·6  8·8  7·5  9·9  10·3  15·9  15·3  1·5  23·1 5·4  12·6  3·1  18·2  7·4   Tanzania  64·9  79·4  159·7  148·0  143·2  195·2  189·3  156·7  232·4 216·4  231·8  205·3  284·7  206·8   Togo  3·9  7·4  7·8  4·6  10·9  17·4  16·3  11·3  12·9 7·3  29·2  6·2  6·3  4·3   Turkmenistan  1·3  1·6  1·9  1·9  2·7  1·4  0·9  0·4  1·3 0·2  1·4  0·4  0·9  0·4   Uganda  67·8  79·5  87·7  186·5  98·3  119·0  124·7  153·1  114·5 159·5  116·7  167·9  192·6  234·7   Uzbekistan  7·5  6·6  9·3  11·4  12·4  16·1  17·5  3·2  17·7 1·5  13·1  3·4  12·8  6·8   Vietnam  50·9  44·6  59·3  58·5  49·6  69·5  65·2  30·9  78·3 25·9  92·9  35·0  34·9  23·5   Yemen  14·9  28·7  52·0  33·0  38·3  40·4  34·4  3·6  45·0 8·1  43·7  1·5  86·0  15·3   Zambia  59·3  66·7  86·1  83·0  96·0  103·5  95·0  123·8  65·4 120·6  106·7  144·2  122·9  141·0   Zimbabwe  15·8  9·8  20·6  25·4  41·2  44·0  75·9  40·0  74·2 78·9  61·9  56·1  187·9  114·5   Grand total  2047·1  2223·7  2935·7  3626·7  3640·6  4367·1  5100·6  2614·6  5221·5  2827·8  5284·3 Disbursements are in constant 2012 US$ (millions). MNCH=maternal, child, and newborn health. R*=Reproductive health. ODA=offi cial development assistance. Mexico, China, and Brazil-all middle-income countries-received the least ODA to child health per child, to MNH per livebirth and to R* per woman of reproductive age in 2011 and 2012. The Solomon Islands received the most for child health per child and for MNH per livebirth in both years. Swaziland, Lesotho, Zambia, and Botswana were among the top fi ve recipients of reproductive health funding per woman of reproductive age in both years.
Results from the regression analyses show that ODA+ to RMNCH continues to be targeted to countries with increased levels of need (the signs on the coeffi cients of 
CH=child health. MNH=maternal and newborn health. R*=reproductive health. ln=natural logarithm. WRA=woman of reproductive age. ODA=offi cial development assistance. 
Discussion
This paper has increased the scope of previous Countdown tracking work by integrating funding for reproductive health and looking more closely at newborn health, thereby more fully refl ecting the continuum of care for RMNCH (panel). Overall ODA+ decreased in 2011 and increased marginally in 2012, yet ODA+ to RMNCH increased consistently during the same time period. Funding to R* increased during the period, although the rate of increase slowed between 2011 and 2012 (and declined when considering all donors to all countries). R* remains heavily dominated by funding earmarked to HIV/AIDS, but there has been a surge in funding for family planning since 2011. The London Family Planning summit which took place in 2012 and the launch of the FP2020 are expected to further increase funding in this area.
Worldwide ODA+ to MNCH increased in 2011 by 5·9% relative to 2010 driven by increased funding to child health, which outweighed a reduction in funds for MNH. ODA to MNCH from the 31 consistent set of donors to the 75 priority countries increased by only 1·2% in 2011 relative to 2010, but increased substantially between 2011 and 2012. The period 2011 and 2012 saw an increase in funding for immunisation and MNH and a steady increase of funding to nutrition. Immunisation funding levels are likely to continue to increase as a result of donor pledges made during the Global Vaccine Summit in Abu Dhabi in April 24-25, 2013 .
We noted an increase in the total funding to newborn health, with a much larger growth in projects that include newborns than those that exclusively target them. We believe this refl ects a growing recognition of the linkage between MNH and the importance of newborn survival in reducing child mortality, with 44% of under-5 deaths being neonatal, and preterm birth now the leading cause of child deaths. 25 Bilateral aid remains the dominant source of funding for RMNCH, with the USA remaining the biggest funder of RMNCH. Reliance on bilateral aid can result in greater volatility in aid disbursements in view of their sensitivity to macroeconomic conditions and domestic politics. For example, the countries most severely hit by the fi nancial crisis decreased their ODA disbursements, with Spain reducing disbursements from $140 million in 2010 to $33 million in 2012; virtually no ODA was given by Greece in 2012, and Italy's ODA fl ows declined in 2012 to the same level as in 2003. Volatility of budgetary contributions has been shown to aff ect recipient governments' ability to plan, 26 undertake long-term investment in health systems, 27 and might result in governments reducing fi nancing of the health sector (fungibility) to prepare for future shocks. 28 Fluctuations in bilateral ODA might also have repercussions on multilateral funding; however, there is no evidence of this so far, and some bilateral organisations, including the UK and French Governments, have a clear policy to invest in multilateral agencies. 29, 30 This study showed evidence of a continued trend towards project-level funding relative to general budget and sector support. Research in Tanzania has shown that, despite budget support being preferred by recipient governments and being less subject to volatility, increased pressure to show results has led to development partners favouring project-based modalities. 31 We report evidence that overall ODA+ remains targeted to countries with increased need, although we did not note evidence of improvement in targeting over time. There was greater evidence of targeting for child and reproductive health compared with maternal and newborn health. Clearly need is only one element in the decision to allocate funds and a range of political and economic and other factors also aff ect these decisions.
Several resource-tracking exercises have been recently undertaken. 6, 9, 32 The IHME recently reported that development assistance to health for MNCH grew by nearly 18% between 2010 and 2011, amounting to $6·1 billion in 2011, 9 whereas we estimated that ODA+ to MNCH was $7·6 billion in 2011, an increase of 5·9% relative to 2010 (appendix p 8). The IHME has not yet reported data for 2012. The PMNCH report estimates that funding to RMNCH remained almost constant in 2011 relative to 2010 at $9·6 billion (growing at 0·5% between 2010 and 2011; converted to 2012 prices from 2005 prices). 6 This value compares to our estimate of $8·3 billion in 2011, an increase of 3·2% relative to 2010. Like us, the PMNCH report estimates a surge in RMNCH funding in 2012 (growing to $10·4 billion, an increase of For more on Family Planning 2020 see http://www. familyplanning2020.org/ 8·8% relative to 2011, with our estimate at $9·3 million, an increase of 11·8%). The UNFPA and NIDI estimate international population assistance totalled $12·0 billion in 2011 and $12·4 billion in 2012. 32 Their defi nition of population activities includes the components of RMNH we analysed and support for demographic-related and programme-related data collection and analysis, research, policy development, and training and reporting, and excludes child health activities. In 2013, the OECD proposed a set of policy markers be introduced for 2014 reporting on 2013 aid fl ows in recognition of activities, which support the achievement of certain MDGs across multiple sectors. The RMNCH policy marker will facilitate tracking aid that is targeted to RMNCH and will be evaluated after a 2-year trial period.
Diff erences in estimates refl ect diff erences in methods used by the various resource-tracking initiatives. First, there is variation in the sources of data used to track resources. IHME estimates development assistance to health, which includes all fi nancial and in-kind contributions from global health channels which aim to improve health; 66% of the data analysed came from sources other than the creditor reporting system, whereas our analysis relies only on the creditor reporting system of the OECD and the donors who report to it. Donors such as China were not included in our assessment, yet their contributions to ODA have been estimated at slightly less than $4 billion per year. 33 PMNCH and UNFPA also draw on the creditor reporting system data, but also held interviews and obtained fi nancing data from additional organisations. Second, there is variation in the coding methods used. The IHME conducts an automated keyword search and allocates certain donors' funding fully to MNCH, such as UNICEF, whereas our method is manual, coding projects with direct relevance to MNCH and including other non-purpose-specifi c funding modalities, general health systems strengthening support, and general budget support that can be attributed to MNCH. PMNCH used the Muskoka method, which relies on the creditor reporting systems' own coding system and assumes a fi xed share of certain codes is allocated to RMNCH. Finally, there are diff erences in the classifi cation of RMNCH categories, which, do not aff ect total RMNCH, but would aff ect the breakdown by component-for example, IHME considers family planning to fall within MNCH, whereas we include it in R*.
9 IHME excludes malaria, tuberculosis, and HIV/AIDS programmes from its estimates of aid for MNCH, whereas we include elements of each that are relevant to MNCH. Undoubtedly, an enhanced dialogue across these tracking initiatives is needed to refl ect on the comparative advantages of the methods that have been used and lessons learnt to facilitate eventual future harmonisation of approaches. Agreement is needed as to which agency should take the lead.
The results shown in this paper are subject to the same limitations with regard to the methods that have been acknowledged previously. [12] [13] [14] [15] The fi rst challenge relates to separating funding to R*, maternal and newborn health, and child health, as well as the programme components therein. Every record is assigned based on the project title and descriptions, which in some cases are complex, vague, or without information about benefi ciaries. Moreover, 37% of our estimate of funding for MNCH was based on assumptions regarding the share of funding for the wider health sector, systems, or policy, which would benefi t mothers and children. Literature informing these assumptions remains scarce and indepth country-level analyses are needed to understand who benefi ts from health fi nancing and how this might vary between countries. Although the estimates of funding to MNCH include health systems or pooled funding resource allocation, the estimate of R* is based only on direct project-level support and is thus likely to be an underestimate. Our models to assess targeting are simple and are not intended to unpack the full range of aid determinants, which would be an important area for future research. Finally, funding to R* is only estimated from 2009 to 2012 and does not include the period 2003-08.
The continued increase in ODA+ to RMNCH at a time of falling overall aid contributions is encouraging, but additional improvements are needed to accelerate progress towards MDGs 4 and 5. Further research is needed to improve the accuracy of resource tracking for RMNCH, along with consensus on the way forward for harmonised and sustainable resource tracking post-2015. www.thelancet.com/lancetgh Vol 3 July 2015
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